Ido Sholt
Professor Ido Sholt is the head of the Maternal-Fetal Medicine Unit at Rambam Health Care Campus in Israel. He is a prominent figure in the field of reproductive health, particularly known for his research on male contraceptives. Recently, he has been in the news for his involvement in clinical trials for a non-hormonal male contraceptive pill, YCT-529, which has shown promising results in animal studies, potentially revolutionizing the landscape of birth control by allowing for a more equitable distribution of contraceptive responsibility between genders.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Israel | 1 | 7.00 | 0.07% | +0% | 9,216,900 | 6,708 | $400,000 | 291$ |
| Totals | 1 | 9,216,900 | 6,708 | $400,000 | 291$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Israel:
Professor Ido Sholt is the head of the maternal-fetal medicine unit and discusses the complex ethical issues surrounding Adriana's case.
7
Israel:
Professor Ido Sholt is the head of the Maternal-Fetal Medicine Unit at Rambam Medical Center and discusses the implications of a new male contraceptive pill.
8